Mark Roskey
Chief Tech/Sci/R&D Officer chez QUANTERIX CORPORATION
Fortune : 452 729 $ au 31/03/2024
Profil
Mark T.
Roskey is currently the Chief Science & Collaboration Officer at Quanterix Corp.
He previously worked as the Marketing Director at Applied Biosystems, Inc. and as the SVP-Applied Biology Research & Development at Caliper Life Sciences, Inc. From 2011 to 2014, he was the Vice President & GM-LST Americas Sales & Services at Revvity, Inc. He also served as the Vice President-Worldwide Marketing at Zymark Corp.
from 2001 to 2003.
Dr. Roskey holds a doctorate degree from the University of Notre Dame and an undergraduate degree from Framingham State College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
QUANTERIX CORPORATION
0,05% | 01/03/2023 | 19 216 ( 0,05% ) | 452 729 $ | 31/03/2024 |
Postes actifs de Mark Roskey
| Sociétés | Poste | Début |
|---|---|---|
| QUANTERIX CORPORATION | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Mark Roskey
| Sociétés | Poste | Fin |
|---|---|---|
| REVVITY, INC. | Corporate Officer/Principal | 01/09/2014 |
Zymark Corp.
 Zymark Corp. Medical SpecialtiesHealth Technology Zymark is a provider of laboratory automation, liquid handling and robotics solutions to the life sciences, biotechnology and pharmaceutical industries. | Sales & Marketing | 01/08/2003 |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Sales & Marketing | - |
Caliper Life Sciences, Inc.
 Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Chief Tech/Sci/R&D Officer | - |
Formation de Mark Roskey
| University of Notre Dame | Doctorate Degree |
| Framingham State College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| REVVITY, INC. | Health Technology |
| QUANTERIX CORPORATION | Health Technology |
| Entreprise privées | 3 |
|---|---|
Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Electronic Technology |
Zymark Corp.
Zymark Corp. Medical SpecialtiesHealth Technology Zymark is a provider of laboratory automation, liquid handling and robotics solutions to the life sciences, biotechnology and pharmaceutical industries. | Health Technology |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
